Brain Cancer Hope: Vaccine Doubles Survival Rate

July 8, 2014  19:28

Agenus Inc said its experimental cancer vaccine helped brain tumor patients live nearly twice as long compared with those who received standard of care treatment, NewsMax Health reported.

The drug, when given in addition to standard treatment, extended median overall survival in 50 percent of newly-diagnosed glioblastoma multiforme (GBM) patients to two years in a mid-stage study.

Usually GBM patients succumb to the disease in one year.

Follow NEWS.am Medicine on Facebook and Twitter


 
  • Read also
 
  • Event calendar
 
 
  • Archive
 
  • Most read
 
  • Find us on Facebook
 
  • Poll
How much money from your income are you willing to allocate monthly on health insurance?
Up to 10,000 drams
Up to 20,000 drams
Up to 50,000 drams
I'm not going to allocate